Sanofi NV25 (SANNV.PA) Stock Cash Flow
Europe - Euronext Paris - EPA:SANNV - FR001400UEY9 - Common Stock
88.5 EUR
0 (0%)
| 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | 2016 (2016-12-31) | 2015 (2015-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 2.81B | 4.31B | 8.42B | 4.71B | 4.29B | |||
| Depreciation Amortization | 7.45B | 4.28B | 3.69B | 3.30B | 4.28B | |||
| Income Taxes - Deferred | -1.75B | -727.00M | -909.00M | -542.00M | -1.25B | |||
| Change In Working Capital | -419.00M | -1.28B | 147.00M | 497.00M | 1.05B | |||
| Interest Paid | 379.00M | 412.00M | 347.00M | 401.00M | 415.00M | |||
| Taxes Paid | 1.70B | 2.06B | 1.73B | 2.10B | 1.78B | |||
| Other non cash items | -342.00M | -1.03B | -3.96B | -112.00M | 532.00M | |||
| OPERATING CASH FLOW | 7.74B | 5.55B | 7.38B | 7.85B | 8.90B | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.82B | -1.98B | -1.96B | -2.08B | -2.77B | |||
| Other Investing Activity | 758.00M | -10.89B | 2.60B | -554.00M | -485.00M | |||
| INVESTING CASH FLOW | -1.06B | -12.87B | 639.00M | -2.64B | -3.26B | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -491.00M | 8.72B | -2.30B | 2.29B | 1.35B | |||
| Stock Issued/Repurchased | 153.00M | -924.00M | -1.84B | -2.60B | -1.21B | |||
| Dividend Paid | -3.83B | -3.77B | -3.71B | -3.76B | -3.69B | |||
| Other Financing Activity | -21.00M | -91.00M | -52.00M | 79.00M | -43.00M | |||
| FINANCING CASH FLOW | -4.19B | 3.93B | -7.90B | -3.99B | -3.60B | |||
| Exchange Rate Effect | 9.00M | 1.00M | -74.00M | -101.00M | -232.00M | |||
| CHANGE IN CASH | 2.50B | -3.39B | 42.00M | 1.13B | 1.81B | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 7.74B | 5.55B | 7.38B | 7.85B | 8.90B | |||
| Capital Expenditure | -1.82B | -1.98B | -1.96B | -2.08B | -2.77B | |||
| FREE CASH FLOW | 5.93B | 3.57B | 5.42B | 5.77B | 6.13B | |||
All data in